Media-OutReach Newswire LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships
Media-OutReach Newswire GangaGen Secures additional US$7.9 Million from CARB-X for Pre-clinical Development of Novel Klebicins Targeting Nosocomial Pneumonia caused by Multidrug-resistant Klebsiella pneumoniae
Society The VinFuture 2024 Grand Prize honours 5 scientists for transformational contributions to the advancement of deep learning
Media-OutReach Newswire The 2024 Vinfuture Prize Honors Four Scientific Works Under The Theme Of "Resilient Rebound"
Media-OutReach Newswire The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration
Media-OutReach Newswire Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine
Media-OutReach Newswire AIM Vaccine’s 13-valent pneumonia conjugate vaccine obtained Production license
Media-OutReach Newswire AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval